{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:12:46Z","timestamp":1788966766680,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.mcn.2026.104116","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:28:19Z","timestamp":1788823699000},"page":"104116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Missense mutations in the SNCA gene: Molecular mechanisms and clinical implications"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4069-4329","authenticated-orcid":false,"given":"Pranaya","family":"Gade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8728-0497","authenticated-orcid":false,"given":"Nishant","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6179-2177","authenticated-orcid":false,"given":"Jamir Pitton","family":"Rissardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7292-8703","authenticated-orcid":false,"given":"Jorge","family":"Patino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8024-2354","authenticated-orcid":false,"given":"Ana Let\u00edcia","family":"Fornari-Caprara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1015-0953","authenticated-orcid":false,"given":"Ian M.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.mcn.2026.104116_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212379","article-title":"Parkinson\u2019s disease: biomarkers for diagnosis and disease progression","volume":"25","author":"Arya","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.mcn.2026.104116_bb0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1086\/302486","article-title":"Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein","volume":"65","author":"Athanassiadou","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mcn.2026.104116_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.407","article-title":"Alpha-synuclein mRNA isoform formation and translation affected by polymorphism in the human SNCA 3\u2019UTR","author":"Barrie","year":"2018","journal-title":"Mol. Genet. Genomic Med."},{"issue":"7362","key":"10.1016\/j.mcn.2026.104116_bb0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"Alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.mcn.2026.104116_bb0025","first-page":"1431","article-title":"Cerebrospinal fluid alpha-synuclein seeding activity in patients with Parkinson\u2019s disease and dementia with Lewy bodies","volume":"37","author":"Bellomo","year":"2022","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.mcn.2026.104116_bb0030","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3390\/biom11121799","article-title":"SNCA 3\u2019 UTR genetic variants in patients with Parkinson\u2019s disease","volume":"11","author":"Bla\u017eekovi\u0107","year":"2021","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.mcn.2026.104116_bb0035","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1021\/bi901723p","article-title":"Differential membrane affinity and aggregation of alpha-synuclein A30P and E46K mutants","volume":"49","author":"Bodner","year":"2010","journal-title":"Biochemistry"},{"issue":"21","key":"10.1016\/j.mcn.2026.104116_bb0040","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1073\/pnas.1315346111","article-title":"Solution conditions determine the relative importance of nucleation and growth processes in alpha-synuclein aggregation","volume":"111","author":"Buell","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.mcn.2026.104116_bb0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41531-025-01137-2","article-title":"Investigating the ageing-Parkinson\u2019s disease nexus: standardisation of in vitro models and techniques by the PD-AGE network","volume":"11","author":"Bury","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"issue":"3","key":"10.1016\/j.mcn.2026.104116_bb0050","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.febslet.2004.09.038","article-title":"Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein","volume":"576","author":"Choi","year":"2004","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.mcn.2026.104116_bb0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10048-008-0138-0","article-title":"Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease","volume":"9","author":"Choi","year":"2008","journal-title":"Neurogenetics"},{"issue":"11","key":"10.1016\/j.mcn.2026.104116_bb0060","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson\u2019s disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"issue":"5785","key":"10.1016\/j.mcn.2026.104116_bb0065","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.1129462","article-title":"Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson\u2019s models","volume":"313","author":"Cooper","year":"2006","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.mcn.2026.104116_bb0070","first-page":"207","article-title":"Association of GBA mutations with the progression of cognitive and motor symptoms in Parkinson\u2019s disease","volume":"75","author":"Davis","year":"2014","journal-title":"Ann. Neurol."},{"issue":"19","key":"10.1016\/j.mcn.2026.104116_bb0075","doi-asserted-by":"crossref","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","article-title":"TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity","volume":"110","author":"Decressac","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2026.104116_bb0080","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.1038\/ncomms8314","article-title":"Missense mutation-induced alpha-synuclein aggregation is effectively scattered by alpha-helical structure","volume":"6","author":"Dettmer","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcn.2026.104116_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00612","article-title":"Parkinson\u2019s disease: biomarkers, treatment, and risk factors","volume":"12","author":"Emamzadeh","year":"2018","journal-title":"Front. Neurosci."},{"issue":"32","key":"10.1016\/j.mcn.2026.104116_bb0090","first-page":"24391","article-title":"Glycation of alpha-synuclein affects its intracellular trafficking and secretion","volume":"285","author":"Emmanouilidou","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2026.104116_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106077","article-title":"Loss of monomeric alpha-synuclein (synucleinopenia) and the origin of Parkinson\u2019s disease","volume":"122","author":"Espay","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"issue":"17","key":"10.1016\/j.mcn.2026.104116_bb0100","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1093\/hmg\/ddu165","article-title":"The novel Parkinson\u2019s disease linked mutation G51D attenuates in vitro aggregation and membrane binding of alpha-synuclein","volume":"23","author":"Fares","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"6776","key":"10.1016\/j.mcn.2026.104116_bb0105","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","article-title":"A Drosophila model of Parkinson\u2019s disease","volume":"404","author":"Feany","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mcn.2026.104116_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/epigenomes7010005","article-title":"SNCA gene methylation in Parkinson\u2019s disease and multiple system atrophy","volume":"7","author":"Fedotova","year":"2023","journal-title":"Epigenomes"},{"issue":"3","key":"10.1016\/j.mcn.2026.104116_bb0115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nchembio.1750","article-title":"Lipid vesicles trigger alpha-synuclein aggregation by stimulating primary nucleation","volume":"11","author":"Galvagnion","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.mcn.2026.104116_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-024-00756-2","article-title":"\u03b1-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson\u2019s disease","volume":"19","author":"Geibl","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.mcn.2026.104116_bb0125","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"issue":"22","key":"10.1016\/j.mcn.2026.104116_bb0130","first-page":"3164","article-title":"The Parkinson\u2019s disease protein alpha-synuclein disrupts cellular vesicle trafficking","volume":"22","author":"Gitler","year":"2008","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.mcn.2026.104116_bb0135","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1074\/jbc.M411638200","article-title":"The E46K mutation in alpha-synuclein increases amyloid fibril formation","volume":"280","author":"Greenbaum","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2026.104116_bb0140","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48907","article-title":"Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy","volume":"8","author":"Guerrero-Ferreira","year":"2019","journal-title":"eLife"},{"issue":"20","key":"10.1016\/j.mcn.2026.104116_bb0145","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1038\/emboj.2010.223","article-title":"Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1","volume":"29","author":"Kamp","year":"2010","journal-title":"EMBO J."},{"issue":"32","key":"10.1016\/j.mcn.2026.104116_bb0150","doi-asserted-by":"crossref","first-page":"21856","DOI":"10.1074\/jbc.M114.553297","article-title":"The H50Q mutation enhances \u03b1-synuclein aggregation, secretion, and toxicity","volume":"289","author":"Khalaf","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.mcn.2026.104116_bb0155","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1399-0004.2007.00781.x","article-title":"The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease","volume":"71","author":"Ki","year":"2007","journal-title":"Clin. Genet."},{"issue":"7","key":"10.1016\/j.mcn.2026.104116_bb0160","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by adeno-associated virus-mediated overexpression of alpha-synuclein in the nigrostriatal system of rats","volume":"22","author":"Kirik","year":"2002","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.mcn.2026.104116_bb0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease","volume":"18","author":"Kr\u00fcger","year":"1998","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.mcn.2026.104116_bb0170","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1212\/WNL.56.10.1355","article-title":"Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers","volume":"56","author":"Kr\u00fcger","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.mcn.2026.104116_bb0175","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.23894","article-title":"G51D \u03b1-synuclein mutation causes a novel parkinsonian-pyramidal syndrome","volume":"73","author":"Lesage","year":"2013","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.mcn.2026.104116_bb0180","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","article-title":"Cryo-EM of full-length alpha-synuclein amyloid fibrils reveals a novel \u201cGreek key\u201d fold","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"issue":"6109","key":"10.1016\/j.mcn.2026.104116_bb0185","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.mcn.2026.104116_bb0190","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.mcn.2026.104116_bb0195","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/nbdi.2001.0392","article-title":"Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter","volume":"8","author":"Matsuoka","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2026.104116_bb0200","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuroscience.2021.05.027","article-title":"Alpha-Synuclein-induced DNA methylation and gene expression in microglia","volume":"468","author":"McGregor","year":"2021","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.mcn.2026.104116_bb0205","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/nn.4641","article-title":"Dopamine induces soluble alpha-synuclein oligomers and nigrostriatal degeneration","volume":"20","author":"Mor","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.mcn.2026.104116_bb0210","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41589-020-0480-6","article-title":"Deep mutational scanning reveals the structural basis for alpha-synuclein activity","volume":"16","author":"Newberry","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.mcn.2026.104116_bb0215","article-title":"Deciphering the alpha-synuclein proteoform landscape in neurodegeneration","volume":"14","author":"Newberry","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.mcn.2026.104116_bb0220","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024109","article-title":"Genetics of synucleinopathies","volume":"8","author":"Nussbaum","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"5","key":"10.1016\/j.mcn.2026.104116_bb0225","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa2202867","article-title":"Trial of prasinezumab in early-stage Parkinson\u2019s disease","volume":"387","author":"Pagano","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.mcn.2026.104116_bb0230","doi-asserted-by":"crossref","first-page":"2180.e1","DOI":"10.1016\/j.neurobiolaging.2014.03.024","article-title":"Novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology","volume":"35","author":"Pasanen","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"7706","key":"10.1016\/j.mcn.2026.104116_bb0235","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","article-title":"Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies","volume":"557","author":"Peng","year":"2018","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1016\/j.mcn.2026.104116_bb0240","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.parkreldis.2015.08.015","article-title":"Phenotypic spectrum of alpha-synuclein mutations: new insights from patients and cellular models","volume":"22","author":"Petrucci","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5321","key":"10.1016\/j.mcn.2026.104116_bb0245","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.mcn.2026.104116_bb0250","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","article-title":"A novel \u03b1-synuclein missense mutation in Parkinson disease","volume":"80","author":"Proukakis","year":"2013","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.mcn.2026.104116_bb0255","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.parkreldis.2009.06.007","article-title":"A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction","volume":"15","author":"Puschmann","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5","key":"10.1016\/j.mcn.2026.104116_bb0260","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","article-title":"Differential neuropathological alterations in transgenic mice expressing wild-type and A53T mutant human alpha-synuclein","volume":"68","author":"Rockenstein","year":"2002","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.mcn.2026.104116_bb0265","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cell.2013.11.009","article-title":"Isogenic human iPSC Parkinson\u2019s model shows nitrosative stress-induced dysfunction in MEF2C-PGC1alpha pathway","volume":"155","author":"Ryan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.mcn.2026.104116_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1236296","article-title":"Mortality and causes of death in patients with Parkinson\u2019s disease: a nationwide population-based cohort study","volume":"14","author":"Ryu","year":"2023","journal-title":"Front. Neurol."},{"issue":"7825","key":"10.1016\/j.mcn.2026.104116_bb0275","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","article-title":"Structures of alpha-synuclein filaments from multiple system atrophy","volume":"585","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.mcn.2026.104116_bb0280","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ana.21966","article-title":"First appraisal of brain pathology owing to A30P mutant alpha-synuclein","volume":"67","author":"Seidel","year":"2010","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.mcn.2026.104116_bb0285","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/genes12081166","article-title":"Roles for \u03b1-synuclein in gene expression","volume":"12","author":"Somayaji","year":"2021","journal-title":"Genes (Basel)"},{"issue":"5","key":"10.1016\/j.mcn.2026.104116_bb0290","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-4159.2006.04310.x","article-title":"Dopaminergic neuron-specific expression of alpha-synuclein, Bak, and Bcl-xL in mice","volume":"100","author":"St Martin","year":"2007","journal-title":"J. Neurochem."},{"issue":"24","key":"10.1016\/j.mcn.2026.104116_bb0295","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1523\/JNEUROSCI.21-24-09549.2001","article-title":"Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-proteasome system","volume":"21","author":"Stefanis","year":"2001","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.mcn.2026.104116_bb0300","doi-asserted-by":"crossref","first-page":"104566","DOI":"10.1016\/j.jbc.2023.104566","article-title":"Cryo-EM structure of amyloid fibril formed by \u03b1-synuclein hereditary A53E mutation reveals a distinct protofilament interface","volume":"299","author":"Sun","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.mcn.2026.104116_bb0305","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.parkreldis.2013.12.002","article-title":"Methylation of \u03b1-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson\u2019s disease patients","volume":"20","author":"Tan","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6161","key":"10.1016\/j.mcn.2026.104116_bb0310","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.1245321","article-title":"Yeast reveal a \u201cdruggable\u201d Rsp5\/Nedd4 network that ameliorates alpha-synuclein toxicity in neurons","volume":"342","author":"Tardiff","year":"2013","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.mcn.2026.104116_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/biom11091333","article-title":"Alpha-Synuclein and the endolysosomal system in Parkinson\u2019s disease: guilty by association","volume":"11","author":"Teixeira","year":"2021","journal-title":"Biomolecules"},{"issue":"7588","key":"10.1016\/j.mcn.2026.104116_bb0320","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature16531","article-title":"Structural disorder of monomeric alpha-synuclein persists in mammalian cells","volume":"530","author":"Theillet","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2026.104116_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00584","article-title":"The landscape of SNCA transcripts across synucleinopathies: new insights from long reads sequencing analysis","volume":"10","author":"Tseng","year":"2019","journal-title":"Front. Genet."},{"issue":"5","key":"10.1016\/j.mcn.2026.104116_bb0330","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nsmb.3194","article-title":"Structure of an alpha-synuclein fibril derived from post-mortem brain tissue","volume":"23","author":"Tuttle","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"10","key":"10.1016\/j.mcn.2026.104116_bb0335","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1074\/jbc.M411805200","article-title":"Structure and dynamics of micelle-bound human alpha-synuclein","volume":"280","author":"Ulmer","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.mcn.2026.104116_bb0340","first-page":"21","article-title":"A protein-chameleon: conformational adaptability of alpha-synuclein to cell microenvironment","volume":"1601","author":"Uversky","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.mcn.2026.104116_bb0345","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","article-title":"The structural differences between patient-derived alpha-synuclein strains dictate characteristics of Parkinson\u2019s disease, multiple system atrophy and dementia with Lewy bodies","volume":"139","author":"Van der Perren","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.mcn.2026.104116_bb0350","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous alpha-synuclein fibrils induce signaling and intracellular sequestration of endogenous alpha-synuclein","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.mcn.2026.104116_bb0355","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/humu.21248","article-title":"Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease","volume":"31","author":"Voutsinas","year":"2010","journal-title":"Hum. Mutat."},{"issue":"43","key":"10.1016\/j.mcn.2026.104116_bb0360","doi-asserted-by":"crossref","first-page":"17797","DOI":"10.1073\/pnas.1113260108","article-title":"A soluble alpha-synuclein construct forms a tetrameric complex","volume":"108","author":"Wang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2026.104116_bb0365","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.12688\/f1000research.12193.1","article-title":"Multiple system atrophy: genetic risks and alpha-synuclein mutations","volume":"6","author":"Whittaker","year":"2017","journal-title":"F1000Research"},{"issue":"Suppl. 1","key":"10.1016\/j.mcn.2026.104116_bb0370","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jnc.13646","article-title":"DNA methylation in Parkinson\u2019s disease","volume":"139","author":"W\u00fcllner","year":"2016","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.mcn.2026.104116_bb0375","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-017-0149-0","article-title":"The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review","volume":"12","author":"Xicoy","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"10","key":"10.1016\/j.mcn.2026.104116_bb0380","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1007\/s00415-016-8213-1","article-title":"The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review","volume":"263","author":"Xiong","year":"2016","journal-title":"J. Neurol."},{"issue":"7933","key":"10.1016\/j.mcn.2026.104116_bb0385","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","article-title":"Structures of \u03b1-synuclein filaments from human brains with Lewy pathology","volume":"610","author":"Yang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2026.104116_bb0390","doi-asserted-by":"crossref","first-page":"248.e7","DOI":"10.1016\/j.neurobiolaging.2017.05.022","article-title":"Homozygous alpha-synuclein p.A53V in familial Parkinson\u2019s disease","volume":"57","author":"Yoshino","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.mcn.2026.104116_bb0395","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743126000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743126000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:23:15Z","timestamp":1788963795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743126000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":79,"alternative-id":["S1044743126000461"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2026.104116","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Missense mutations in the SNCA gene: Molecular mechanisms and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2026.104116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104116"}}